ENTPD1 and neoplasm: Further, upregulated expression of CD39 (ENTPD1) was detected, a marker of persistent TCR stimulation on exhaustive T cells (17, 53), co-expression of which with tissue-resident memory T cell marker CD103 (ITGAE) has been identified on tumor-reactive CD8-positive T cells in human solid cancers (17).